# Definium Therapeutics, Inc.: Form 8-K, filed Mar 28, 2022

- Company: [Definium Therapeutics, Inc.](/companies/dftx.md) (CIK 1813814)
- Form: 8-K
- Filed: 2022-03-28
- Accepted by EDGAR: Mar 28, 2022, 17:11 ET
- Period: 2022-03-28
- Accession: 0000950170-22-004801
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1813814/000095017022004801/mnmd-20220328.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1813814/000095017022004801/

## Items reported

- Item 2.02: Results of operations
- Item 4.01: Change of auditor
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1813814/000095017022004801/mnmd-20220328.htm

Filed Mar 28, 2022.
Source: SEC EDGAR, the filing index for accession 0000950170-22-004801. Last ingested by Listed: Nov 5, 2026, 13:55 ET. No prices; not investment advice.